Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Nevro

Nevro

Nevro is a medical device company with the simple goal of helping more patients who are suffering from chronic pain to achieve lasting relief.

Nevro is a medical device company with the simple goal of helping more patients who are suffering from chronic pain to achieve lasting relief. Nevro pursues clinical research to better support healthcare providers in treating chronic pain.

The company creates HFX, a comprehensive solution for individualized relief of chronic pain to help physicians to meet the diverse needs of patients by providing: Innovative Technologies, Advanced Therapies, Services & Support and Meaningful Evidence.

Nevro created a disruption by offering a next-generation approach called 10 kHz Therapy, the most studied therapy in the market, that provides patients with significant pain relief and no paresthesia.

The company's product, Nevro® Senza® SCS System for 10 kHz Therapy, received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.

Timeline

March 7, 2013
Nevro raises a $48,000,000 series C round from Accuitive Medical Ventures, Bay City Capital, Covidien Ventures, Johnson & Johnson Development Corporation, MPM Capital, Mayo Clinic, New Enterprise Associates, Novo Ventures and Three Arch Partners.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Conor Hale
July 19, 2021
FierceBiotech
Compared to spinal cord stimulators that may deliver under 200 electrical pulses-per-second to disrupt chronic pain, Nevro's device provides 10,000 to offer relief without uncomfortable tingling sensations.
Nevro Corp.
June 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
June 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
June 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.